Cargando…
Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool
STUDY DESIGN: Prospective observational study. OBJECTIVES: A tool to help decision-making tool for Neurogenic Bowel Dysfunction (NBD) in individuals with SCI is needed. We present a project to create and validate a new tool, the Monitoring Efficacy of NBD Treatment On Response (MENTOR), and to deter...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340621/ https://www.ncbi.nlm.nih.gov/pubmed/31988365 http://dx.doi.org/10.1038/s41393-020-0424-8 |
_version_ | 1783555068403908608 |
---|---|
author | Emmanuel, Anton Krogh, Klaus Kirshblum, Steven Christensen, Peter Spinelli, Michele van Kuppevelt, Dirk Abel, Rainer Leder, Dietrich Santacruz, Bruno Gallo Bain, Kimberly Passananti, Valentina |
author_facet | Emmanuel, Anton Krogh, Klaus Kirshblum, Steven Christensen, Peter Spinelli, Michele van Kuppevelt, Dirk Abel, Rainer Leder, Dietrich Santacruz, Bruno Gallo Bain, Kimberly Passananti, Valentina |
author_sort | Emmanuel, Anton |
collection | PubMed |
description | STUDY DESIGN: Prospective observational study. OBJECTIVES: A tool to help decision-making tool for Neurogenic Bowel Dysfunction (NBD) in individuals with SCI is needed. We present a project to create and validate a new tool, the Monitoring Efficacy of NBD Treatment On Response (MENTOR), and to determine its level of concordance with decisions made by experienced clinicians in the field. SETTING: UK, Denmark, USA, Italy, The Netherlands, Germany. METHODS: The first phase was creation of the tool through a modified Delphi process. The second phase was the validation, wherein individuals with spinal cord injury with NBD were asked to complete the MENTOR tool immediately prior to clinic consultation. From the responses to the questionnaire of the tool, each participant was allocated into one of three categories reflecting the possible therapeutic recommendations (“recommend change”, “further discussion” and “monitoring”). An expert clinician then assessed the participant, blinded to MENTOR results, and made an independent treatment decision. RESULTS: A total of 248 MENTOR forms were completed. Strong agreement was found when the MENTOR tool recommended monitoring (92%) or treatment change (83%); the lowest concordance when the decision was for the “further discussion” option (59%). Patient acceptability was reported by 97% of individuals. CONCLUSIONS: MENTOR is an easy to use tool to monitor the treatment of NBD and determinate progression through the clinical pathway. This validation study shows good correspondence between expert clinician opinion and MENTOR result. The tool has potential to be used in other patient groups, following further studies. |
format | Online Article Text |
id | pubmed-7340621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-73406212020-07-15 Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool Emmanuel, Anton Krogh, Klaus Kirshblum, Steven Christensen, Peter Spinelli, Michele van Kuppevelt, Dirk Abel, Rainer Leder, Dietrich Santacruz, Bruno Gallo Bain, Kimberly Passananti, Valentina Spinal Cord Article STUDY DESIGN: Prospective observational study. OBJECTIVES: A tool to help decision-making tool for Neurogenic Bowel Dysfunction (NBD) in individuals with SCI is needed. We present a project to create and validate a new tool, the Monitoring Efficacy of NBD Treatment On Response (MENTOR), and to determine its level of concordance with decisions made by experienced clinicians in the field. SETTING: UK, Denmark, USA, Italy, The Netherlands, Germany. METHODS: The first phase was creation of the tool through a modified Delphi process. The second phase was the validation, wherein individuals with spinal cord injury with NBD were asked to complete the MENTOR tool immediately prior to clinic consultation. From the responses to the questionnaire of the tool, each participant was allocated into one of three categories reflecting the possible therapeutic recommendations (“recommend change”, “further discussion” and “monitoring”). An expert clinician then assessed the participant, blinded to MENTOR results, and made an independent treatment decision. RESULTS: A total of 248 MENTOR forms were completed. Strong agreement was found when the MENTOR tool recommended monitoring (92%) or treatment change (83%); the lowest concordance when the decision was for the “further discussion” option (59%). Patient acceptability was reported by 97% of individuals. CONCLUSIONS: MENTOR is an easy to use tool to monitor the treatment of NBD and determinate progression through the clinical pathway. This validation study shows good correspondence between expert clinician opinion and MENTOR result. The tool has potential to be used in other patient groups, following further studies. Nature Publishing Group UK 2020-01-27 2020 /pmc/articles/PMC7340621/ /pubmed/31988365 http://dx.doi.org/10.1038/s41393-020-0424-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Emmanuel, Anton Krogh, Klaus Kirshblum, Steven Christensen, Peter Spinelli, Michele van Kuppevelt, Dirk Abel, Rainer Leder, Dietrich Santacruz, Bruno Gallo Bain, Kimberly Passananti, Valentina Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool |
title | Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool |
title_full | Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool |
title_fullStr | Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool |
title_full_unstemmed | Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool |
title_short | Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool |
title_sort | creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the mentor tool |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340621/ https://www.ncbi.nlm.nih.gov/pubmed/31988365 http://dx.doi.org/10.1038/s41393-020-0424-8 |
work_keys_str_mv | AT emmanuelanton creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool AT kroghklaus creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool AT kirshblumsteven creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool AT christensenpeter creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool AT spinellimichele creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool AT vankuppeveltdirk creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool AT abelrainer creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool AT lederdietrich creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool AT santacruzbrunogallo creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool AT bainkimberly creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool AT passanantivalentina creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool |